Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. COST
2. SPY
3. AKAM
4. META
5. NVDA
6. ZS
7. CRL
8. OKTA
9. VEON
10. PRME

Go back to Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
Merck & Co. (NYSE: MRK) Delayed: 148.78 --0 (-0%)
Previous Close $148.78    52 Week High $65.46 
Open $148.78    52 Week Low $47.97 
Day High $148.78    P/E 101.21 
Day Low $148.78    EPS $1.47 
Volume 2,487